The latest study on Biosimilar Monoclonal Antibody Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Biosimilar Monoclonal Antibody Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Biosimilar Monoclonal Antibody and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis
Biosimilar Monoclonal Antibody Market Analysis By Type Segment:
Synthetic Chemicals
Biopharmaceuticals
Others
Biosimilar Monoclonal Antibody Market Analysis By Application Segment:
Chronic & Autoimmune Diseases
Oncology
Others
Biosimilar Monoclonal Antibody Market Analysis By Regions (Countries):
The Biosimilar Monoclonal Antibody Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Biosimilar Monoclonal Antibody Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Biosimilar Monoclonal Antibody Market:
Biosimilar Monoclonal Antibody market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Biosimilar Monoclonal Antibody Market status and future forecast.
To present the key Biosimilar Monoclonal Antibody Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type (2016-2027)
1.4.2 Synthetic Chemicals
1.4.3 Biopharmaceuticals
1.4.4 Others
1.5 Market by Application
1.5.1 Global Biosimilar Monoclonal Antibody Market Share by Application (2016-2027)
1.5.2 Chronic & Autoimmune Diseases
1.5.3 Oncology
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biosimilar Monoclonal Antibody Market Size
2.2 Biosimilar Monoclonal Antibody Growth Trends by Regions
2.2.1 Biosimilar Monoclonal Antibody Market Size by Regions (2016-2027)
2.2.2 Biosimilar Monoclonal Antibody Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biosimilar Monoclonal Antibody Market Size by Manufacturers
3.1.1 Global Biosimilar Monoclonal Antibody Revenue by Manufacturers (2020)
3.1.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Manufacturers (2020)
3.1.3 Global Biosimilar Monoclonal Antibody Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar Monoclonal Antibody Key Players Head office and Area Served
3.3 Key Players Biosimilar Monoclonal Antibody Product/Solution/Service
3.4 Date of Enter into Biosimilar Monoclonal Antibody Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biosimilar Monoclonal Antibody Market Size by Type (2016-2020)
4.2 Global Biosimilar Monoclonal Antibody Market Size by Application (2016-2020)
5 United States
5.1 United States Biosimilar Monoclonal Antibody Market Size (2016-2020)
5.2 Biosimilar Monoclonal Antibody Key Players in United States
5.3 United States Biosimilar Monoclonal Antibody Market Size by Type
5.4 United States Biosimilar Monoclonal Antibody Market Size by Application
6 Europe
6.1 Europe Biosimilar Monoclonal Antibody Market Size (2016-2020)
6.2 Biosimilar Monoclonal Antibody Key Players in Europe
6.3 Europe Biosimilar Monoclonal Antibody Market Size by Type
6.4 Europe Biosimilar Monoclonal Antibody Market Size by Application
7 China
7.1 China Biosimilar Monoclonal Antibody Market Size (2016-2020)
7.2 Biosimilar Monoclonal Antibody Key Players in China
7.3 China Biosimilar Monoclonal Antibody Market Size by Type
7.4 China Biosimilar Monoclonal Antibody Market Size by Application
8 Japan
8.1 Japan Biosimilar Monoclonal Antibody Market Size (2016-2020)
8.2 Biosimilar Monoclonal Antibody Key Players in Japan
8.3 Japan Biosimilar Monoclonal Antibody Market Size by Type
8.4 Japan Biosimilar Monoclonal Antibody Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Biosimilar Monoclonal Antibody Market Size (2016-2020)
9.2 Biosimilar Monoclonal Antibody Key Players in Southeast Asia
9.3 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type
9.4 Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application
10 India
10.1 India Biosimilar Monoclonal Antibody Market Size (2016-2020)
10.2 Biosimilar Monoclonal Antibody Key Players in India
10.3 India Biosimilar Monoclonal Antibody Market Size by Type
10.4 India Biosimilar Monoclonal Antibody Market Size by Application
11 Central & South America
11.1 Central & South America Biosimilar Monoclonal Antibody Market Size (2016-2020)
11.2 Biosimilar Monoclonal Antibody Key Players in Central & South America
11.3 Central & South America Biosimilar Monoclonal Antibody Market Size by Type
11.4 Central & South America Biosimilar Monoclonal Antibody Market Size by Application
12 International Players Profiles
12.1 Biocon
12.1.1 Biocon Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilar Monoclonal Antibody Introduction
12.1.4 Biocon Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.1.5 Biocon Recent Development
12.2 Accord Healthcare
12.2.1 Accord Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilar Monoclonal Antibody Introduction
12.2.4 Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.2.5 Accord Healthcare Recent Development
12.3 AET Biotech
12.3.1 AET Biotech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilar Monoclonal Antibody Introduction
12.3.4 AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.3.5 AET Biotech Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilar Monoclonal Antibody Introduction
12.4.4 Amgen Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.4.5 Amgen Recent Development
12.5 Celltrion
12.5.1 Celltrion Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilar Monoclonal Antibody Introduction
12.5.4 Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.5.5 Celltrion Recent Development
12.6 Reddy's Laboratories
12.6.1 Reddy's Laboratories Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilar Monoclonal Antibody Introduction
12.6.4 Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.6.5 Reddy's Laboratories Recent Development
12.7 Hospira
12.7.1 Hospira Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilar Monoclonal Antibody Introduction
12.7.4 Hospira Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.7.5 Hospira Recent Development
12.8 3SBio
12.8.1 3SBio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilar Monoclonal Antibody Introduction
12.8.4 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.8.5 3SBio Recent Development
12.9 Allergan
12.9.1 Allergan Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilar Monoclonal Antibody Introduction
12.9.4 Allergan Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.9.5 Allergan Recent Development
12.10 Alvartis
12.10.1 Alvartis Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biosimilar Monoclonal Antibody Introduction
12.10.4 Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2020)
12.10.5 Alvartis Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Biosimilar Monoclonal Antibody Key Market Segments
Table Key Players Biosimilar Monoclonal Antibody Covered
Table Global Biosimilar Monoclonal Antibody Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Type 2016-2027
Figure Synthetic Chemicals Figures
Table Key Players of Synthetic Chemicals
Figure Biopharmaceuticals Figures
Table Key Players of Biopharmaceuticals
Figure Others Figures
Table Key Players of Others
Table Global Biosimilar Monoclonal Antibody Market Size Growth by Application 2016-2027 (Million US$)
Figure Chronic & Autoimmune Diseases Case Studies
Figure Oncology Case Studies
Figure Others Case Studies
Figure Biosimilar Monoclonal Antibody Report Years Considered
Table Global Biosimilar Monoclonal Antibody Market Size 2016-2027 (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size by Regions 2016-2027 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size by Regions 2016-2020 (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Share by Regions 2016-2020
Figure Global Biosimilar Monoclonal Antibody Market Share by Regions 2016-2020
Figure Global Biosimilar Monoclonal Antibody Market Share by Regions 2020
Table Market Top Trends
Table Global Biosimilar Monoclonal Antibody Revenue by Manufacturers (2020) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Share by Manufacturers (2020)
Figure Global Biosimilar Monoclonal Antibody Market Share by Manufacturers in 2020
Table Global Biosimilar Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilar Monoclonal Antibody Product/Solution/Service
Table Date of Enter into Biosimilar Monoclonal Antibody Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size Share by Type (2016-2020)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Type (2016-2020)
Table Global Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table Global Biosimilar Monoclonal Antibody Market Size Share by Application (2016-2020)
Figure Global Biosimilar Monoclonal Antibody Market Size Market Share by Application (2016-2020)
Figure Global Biosimilar Monoclonal Antibody Revenue Market Share by Application in 2020
Figure United States Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table United States Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table United States Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table United States Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table United States Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table United States Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table United States Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure Europe Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table Europe Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table Europe Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table Europe Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table Europe Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table Europe Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table Europe Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure China Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table China Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table China Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table China Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table China Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table China Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table China Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure Japan Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table Japan Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table Japan Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table Japan Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table Japan Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table Japan Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table Japan Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure Southeast Asia Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table Southeast Asia Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure India Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table India Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table India Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table India Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table India Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table India Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table India Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Figure Central & South America Biosimilar Monoclonal Antibody Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Biosimilar Monoclonal Antibody Revenue (2020) (Million US$)
Table Central & South America Key Players Biosimilar Monoclonal Antibody Market Share (2020)
Table Central & South America Biosimilar Monoclonal Antibody Market Size by Type (2016-2020) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibody Market Share by Type (2016-2020)
Table Central & South America Biosimilar Monoclonal Antibody Market Size by Application (2016-2020) (Million US$)
Table Central & South America Biosimilar Monoclonal Antibody Market Share by Application (2016-2020)
Table Biocon Company Details
Table Biocon Revenue in Biosimilar Monoclonal Antibody Business (2020) (Million US$)
Figure Biocon Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Biocon Recent Development
Table Accord Healthcare Company Details
Table Accord Healthcare Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Accord Healthcare Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Accord Healthcare Recent Development
Table AET Biotech Company Details
Table AET Biotech Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure AET Biotech Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table AET Biotech Recent Development
Table Amgen Company Details
Table Amgen Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Amgen Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Amgen Recent Development
Table Celltrion Company Details
Table Celltrion Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Celltrion Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Celltrion Recent Development
Table Reddy's Laboratories Company Details
Table Reddy's Laboratories Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Reddy's Laboratories Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Reddy's Laboratories Recent Development
Table Hospira Company Details
Table Hospira Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Hospira Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Hospira Recent Development
Table 3SBio Company Details
Table 3SBio Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure 3SBio Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table 3SBio Recent Development
Table Allergan Company Details
Table Allergan Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Allergan Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Allergan Recent Development
Table Alvartis Company Details
Table Alvartis Revenue in Biosimilar Monoclonal Antibody Business (2020)(Million US$)
Figure Alvartis Revenue Growth Rate in Biosimilar Monoclonal Antibody Business (2020)
Table Alvartis Recent Development
Table Global Biosimilar Monoclonal Antibody Market Size by Regions (Million US$) 2021-2027
Figure Global Biosimilar Monoclonal Antibody Market Size Share by Regions (2021-2027)
Figure Global Biosimilar Monoclonal Antibody Market Size Share by Regions in 2027
Figure United States Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure Europe Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure China Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure Japan Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure India Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Biosimilar Monoclonal Antibody Market Size Forecast (2021-2027)(Million USD)
Table Global Biosimilar Monoclonal Antibody Market Size by Product (2021-2027) (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size by Product (2021-2027)
Figure Global Biosimilar Monoclonal Antibody Market Size by Product in 2027
Table Global Biosimilar Monoclonal Antibody Market Size by Application (2021-2027) (Million US$)
Figure Global Biosimilar Monoclonal Antibody Market Size by Application (2021-2027)
Figure Global Biosimilar Monoclonal Antibody Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources